Skip to main content
. 2019 Dec 7;25(45):6668–6680. doi: 10.3748/wjg.v25.i45.6668

Table 3.

Discrimination and calibration assessments of all the scoring systems for in-hospital adverse outcomes

Score AUROC 95%CI P value AUROC difference 95%CI P value H-L test, P value
In-hospital rebleeding
CTP 0.717 0.648-0.787 < 0.001 Reference 0.134
CRS 0.716 0.638-0.793 < 0.001 0.0016 -0.0851-0.0883 0.9713 0.062
MELD-Na 0.680 0.609-0.752 < 0.001 0.0369 -0.0266-0.1000 0.2547 0.613
MELD 0.661 0.588-0.734 < 0.001 0.0560 -0.0026-0.1150 0.0610 0.386
CANUKA 0.656 0.579-0.732 < 0.001 0.0614 -0.0237- 0.1470 0.1575 0.186
AIMS65 0.642 0.565-0.719 < 0.001 0.0753 0.0120 - 0.1380 0.0196 0.321
GBS 0.617 0.534-0.699 0.003 0.1010 0.0153 - 0.1860 0.0208 0.041
mGBS 0.600 0.518-0.683 0.011 0.1170 0.0314 - 0.2020 0.0074 0.064
In-hospital mortality
CRS 0.883 0.822-0.943 < 0.001 Reference 0.166
CTP 0.878 0.825-0.931 < 0.001 0.0047 -0.0620-0.0714 0.8901 0.566
AIMS65 0.856 0.787-0.925 < 0.001 0.0269 -0.0390-0.0928 0.4232 0.175
MELD-Na 0.856 0.786-0.925 < 0.001 0.0271 -0.0453-0.0995 0.4630 0.636
MELD 0.840 0.767-0.914 < 0.001 0.0423 -0.0360- 0.1210 0.2900 0.472
mGBS 0.734 0.631-0.838 < 0.001 0.1480 0.0552-0.2420 0.0018 0.013
CANUKA 0.728 0.627-0.830 < 0.001 0.1540 0.0675-0.2410 0.0005 0.046
GBS 0.723 0.621-0.826 < 0.001 0.1590 0.0668-0.2520 0.0007 0.004
In-hospital adverse outcomes
CTP 0.784 0.725-0.843 < 0.001 Reference 0.218
CRS 0.775 0.709-0.841 < 0.001 0.0087 -0.0650-0.0824 0.8171 0.002
MELD-Na 0.739 0.675-0.803 < 0.001 0.0446 -0.0136-0.1030 0.1335 0.723
MELD 0.724 0.659-0.789 < 0.001 0.0598 0.0074-0.1120 0.0254 0.464
AIMS65 0.711 0.642-0.780 < 0.001 0.0728 0.0160-0.1300 0.0120 0.101
CANUKA 0.677 0.606-0.748 < 0.001 0.1070 0.0274-0.1860 0.0084 0.023
GBS 0.656 0.582-0.729 < 0.001 0.1280 0.0516-0.2050 0.0010 0.008
mGBS 0.649 0.574-0.723 < 0.001 0.1350 0.0586-0.2120 0.0005 0.024

AUROC: Area under the receiver operating characteristic curve; CI: Confidence interval; H-L: Hosmer-Lemeshow; CTP: Child-Turcotte-Pugh score; MELD: Model for end-stage liver disease; CRS: Clinical Rockall score; GBS: Glasgow-Blatchford score; mGBS: Modified Glasgow-Blatchford score; AIMS65: AIMS65 score; CANUKA: Canada-United Kingdom-Australia score.